Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY19.57 CNY
Change Today 0.00 / 0.00%
Volume 0.0
As of 3:05 AM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

zhenxing biopharmaceutical-a (000403) Snapshot

Open
--
Previous Close
CNY19.57
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
CNY0.12
Shares Outstanding
272.6M
EX-Date
04/7/04
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ZHENXING BIOPHARMACEUTICAL-A (000403)

Related News

No related news articles were found.

zhenxing biopharmaceutical-a (000403) Related Businessweek News

No Related Businessweek News Found

zhenxing biopharmaceutical-a (000403) Details

Zhenxing Biopharmaceutical and Chemical Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), human rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, tianqi analgesic cream, musk herd cream, musk bone paste, anti-inflammatory analgesic cream, dieshangling plasters, and medical gauzes. The company is also involved in the development of porcine pulmonary surfactants, shaqifang compounds, a1-protease inhibitors, human coagulation factor VIII products, and human fibrinogens. In addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; real estate development; and electronic product information consultation, as well as in the provision of electricity. The company was formerly known as Sanjiu Yigong Biopharmaceutical Co., Ltd. to Zhenxing Biopharmaceutical and Chemical Co., Ltd. in June 2010. Zhenxing Biopharmaceutical and Chemical Co., Ltd. is based in Taiyuan, China. Zhenxing Biopharmaceutical and Chemical Co., Ltd. is a subsidiary of Zhenxing Group Co., Ltd.

zhenxing biopharmaceutical-a (000403) Top Compensated Officers

Chairman and General Manager
Total Annual Compensation: --
Chief Financial Officer, Deputy General Manag...
Total Annual Compensation: --
Deputy General Manager
Total Annual Compensation: --
Executive Deputy General Manager, Secretary o...
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

zhenxing biopharmaceutical-a (000403) Key Developments

ST ZXBC, Annual General Meeting, Jun 26, 2015

ST ZXBC, Annual General Meeting, Jun 26, 2015., at 14:00 China Standard Time. Agenda: To consider the 2014 annual report and its summary; to consider the 2014 work report of the board of directors; to consider the 2014 work report of the supervisory committee; to consider the 2014 financial resolution report; to consider the 2014 profit distribution plan; to consider the reappointment of 2015 financial audit firm; to consider the reappointment of 2015 inner control audit firm; to consider the provision for asset depreciation and estimated liabilities; and to consider the financial aid to a company.

Zhenxing Biopharmaceutical and Chemical Co.,Ltd. to Report Q1, 2015 Results on Apr 30, 2015

Zhenxing Biopharmaceutical and Chemical Co.,Ltd. announced that they will report Q1, 2015 results on Apr 30, 2015

Zhenxing Biopharmaceutical and Chemical Co.,Ltd. to Report Fiscal Year 2014 Results on Apr 30, 2015

Zhenxing Biopharmaceutical and Chemical Co.,Ltd. announced that they will report fiscal year 2014 results on Apr 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000403:CH CNY19.57 CNY 0.00

000403 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000403.
View Industry Companies
 

Industry Analysis

000403

Industry Average

Valuation 000403 Industry Range
Price/Earnings 100.0x
Price/Sales 10.5x
Price/Book 12.4x
Price/Cash Flow 163.9x
TEV/Sales 9.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHENXING BIOPHARMACEUTICAL-A, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.